Loading

Journal of Addiction Medicine and Therapy

Health Effects of Cigarette Smoking and E-Cigarette Vaping on Respiratory Function among Adolescents: Systematic Literature Review

Research Article | Open Access | Volume 13 | Issue 1
Article DOI :

  • 1. Australian College of Business and Technology, University of Kelaniya, Sri Lanka
+ Show More - Show Less
Corresponding Authors
Rayandi Christina, Australian College of Business and Technology, University of Kelaniya, Sri Lanka
Abstract

Background: Cigarette smoking and e-cigarette vaping among adolescents is a big problem in worldwide. Cigarette smoking causes respiratory disorders such as COPD, Lung Cancer, Asthma Exacerbation as well as e-cigarette vaping also causes Lung Injury, Bronchiolitis Obliterans, Airway Resistance, Decreased Immune Function etc. E-cigarettes are less harmful compared to combustible cigarettes; but both are harmful for the respiratory function. Therefore this systematic literature review aims to evaluate and compare the health effects of cigarette smoking and e-cigarette vaing on respiratory function among adolescents.

Methods: This systematic literature review was performed using databases such as Google Scholar, MEDLINE, PubMed, Research Gate, and Web of Science. Articles published between 2013 and 2026 on health effects, cigarette smoking, e-cigarette vaping, respiratory function, and adolescents was searched using specific key terms.

Results: The results obtained from the reviewed articles showed that smoking cigarettes can lead to low lung function, airway inflammation, persistent cough and wheezing. Similarly the use of e-cigarettes has been found to cause respiratory issues such as airway inflammation, cough and mild decrease in lung function. However the evidence also shows that vaping isn’t free of health risks and it can cause early respiratory complications among adolescents.

Conclusion: In general this review indicates that although e-cigarettes have fewer respiratory consequences compared to conventional cigarettes, both types of nicotine intake are linked with poor respiratory outcomes in adolescents. It is important for preventive measures to be taken to ensure that adolescents engage in neither activity.

Keywords

• Health Effects

• Cigarette Smoking

• E-cigarette Vaping

• Respiratory Function

• Adolescents

Citation

Christina R, Silva D, Ekanayake A, Madurapperuma W (2026) Health Effects of Cigarette Smoking and E-Cigarette Vaping on Respiratory Function among Adolescents: Systematic Literature Review. J Addict Med Ther 13(1): 1054.

INTRODUCTION

E-cigarette (vaporizer) use among adolescents has raised significant public health concerns, particularly regarding its comparative safety relative to conventional cigarette smoking. While e-cigarettes are often marketed as safer alternatives, emerging evidence indicates that both vaping and traditional smoking pose substantial health risks to adolescents [1-4]. While vaping is generally considered less harmful than combustible tobacco, neither vaping nor smoking is free from danger [1-5]. Electronic cigarettes are devices with a heating element which produces aerosol for inhalation. They have been propagated as a healthier alternative to tobacco smoking and a potential device for smoking cessation, despite non documentation of their long term adverse health effects [6-14]. E-cigarette use by a person who has never smoked may cause harm to the respiratory system compared with never using e-cigarettes, particularly if initiation of e-cigarettes occurs at a young age [15-20]. Exposure of the dual user to both combustible tobacco products and e-cigarette aerosols may cause unique health risks to the respiratory system [15-21]. Smoking of combustible tobacco products is the number one cause of Chronic Obstructive Pulmonary Disease (COPD) worldwide. Although the proportion of smokers has decreased over the past 25 years, approximately 1.1 billlion people continue to smoke as of 2015 [15-25].

The worldwide average of current vaping among youths at roughly 9%, with national figures ranging from under 2% in some countries to over 30% in others. In Europe, e-cigarette use among adolescents aged 13-15 years varies significantly, from less than 1% in some countries to over 20% in others, with several nations reporting that youth vaping now surpasses cigarette smoking in popularity. By contrast, many Asian countries have recorded lower youth vaping rates: surveys in Japan and South Korea found only about 3.5 and 10%, respectively, of adolescents had ever tried e-cigarettes, and a study in China observed just ~1% current use among middle school students. Overall, despite regional differences, the emergence of e-cigarettes has become a global phenomenon among youth, with rapid uptake observed across North America, Europe, and other parts of the world [26]. One large survey of never smokers reported that current e-cigarette users had about 39% higher odds of self reported asthma than non users, with a dose response relationship (daily vapers showed the greatest risk increase). More acute clinical reports have further underscored vaping’s potential for harm: in 2019, an outbreak of e-cigarette or vaping associated acute lung injury in the US resulted in over 2800 hospitalizations and 68 confirmed deaths, predominantly in adolescents and young adults. Taken together, current findings, from symptoms and airway reactivity to rare catastrophic injuries, implicate e-cigarette use as detrimental to adolescent pulmonary function and respiratory well being [26-31]. Exposure of the lungs to various components of the e-cigarette aerosol could potentially damage the respiratory system or worsen pre-existing lung disease through a variety of mechanisms. For example, nicotine containing e-cigarette aerosols have the potential to adversely impact several host defense mechanisms in the lungs. In a murine model, α7 nicotine acetylcholine receptors (α7 nAChRs) were shown to regulate Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) activity in the airways. Exposure to nicotine downregulated α7 nAChR activity, which in turn impaired CFTR function, causing impaired mucociliary clearance (MCC). In humans, CFTR dysfunction has been shown to be associated with the development of COPD and asthma hyperresponsiveness. Exposure to nicotine in tobacco smoke and e-cigarette aerosols also has been reported to impair cough [15 32]. And also exposure to heavy metals originating from e-cigarette coils and components has been associated with adverse respiratory outcomes in adolescents. Inhaled metals such as nickel and chromium (commonly leached from heating coils) can deposit in lung tissue and have been associated with chronic airway inflammation and fibrosis [26-33]. Many current studies on adolescent e-cigarette use, pulmonary function, and physical activity have significant methodological limitations. Research to date is dominated by cross sectional designs and relies heavily on self reported data for both e-cigarette exposure and health outcomes [26]. Without prospective longitudinal research, questions remain about whether early e-cigarette use leads to lasting decrements in spirometry indices or exercise performance later in life. The literature’s emphasis on short study horizons means we do not yet know if any subclinical pulmonary changes in youth might progress to clinically significant deficits over time. Longitudinal studies with extended follow up are critically needed to clarify these long term trajectories [26].

MATERIALS AND METHODS

A systematic review was conducted to evaluate the health effects of cigarette smoking and e-cigarette vaping on respiratory function among adolescents. The methodology used in this discussion is a qualitative description. It involves summarizing and synthesizing information from various sources, presenting insights from different studies, and offering an overview of the research landscape. A comprehensive search was conducted using the following databases: Google Scholar, MEDLINE, PubMed, ResearchGate, and Web of Science. The search terms included “Health Effects”, “Cigarette Smoking”, “E-cigarette Vaping”, “Respiratory Function”, and “Adolescents”. The search was limited to studies published in English between 2013 and 2026 to ensure the inclusion of recent and relevant research. The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta Analyses) framework was utilized to guide the review process (Figure 1).

https://www.jscimedcentral.com/public/assets/images/uploads/image-1787115680-1.PNG

Figure 1: Identification of Studies via Databases and Registers

Studies were included if they focused on the respiratory health effects of cigarette smoking and e-cigarette vaping among adolescents, including physical and respiratory outcomes such as lung function impairment, respiratory symptoms, or respiratory diseases. Studies comparing the harmful effects of combustible cigarettes and e-cigarettes were also included. Articles unrelated to respiratory health outcomes, non English articles, those not involving adolescents as the target population, or studies focused exclusively on adults were excluded.

Study Selection Criteria

Studies were included in the review if they met the following criteria: (1) focused on the health effects of cigarette smoking and e-cigarette vaping on respiratory function, (2) included adolescents as the primary population, (3) examined either or both combustible cigarettes and e-cigarettes to allow comparison of their harmful effects, (4) utilized quantitative, qualitative, or mixed research methods, and (5) reported outcomes related to respiratory health, such as lung function, respiratory symptoms, or respiratory diseases. Studies were excluded if they did not specifically address cigarette smoking or e-cigarette vaping, did not include adolescents as the target population, were not available in full text form, were published in a language other than English, or lacked relevant respiratory outcomes. The research process yielded a total of 77 articles meeting the eligibility criteria.

Literature Management

Zotero, a reference management tool, was used to store and organize the collected articles. This tool allowed for efficient handling and retrieval of literature, ensuring a systematic and organized research process.

Data Extraction and Analysis

Extracted data were transferred to Microsoft Excel Sheets, where graphs and tables were created to visually present trends, patterns, and key findings. Keywords and themes were identified using VOSviewer software, which helped highlight recurring concepts related to the health effects of cigarette smoking and e-cigarette vaping on respiratory function among adolescents, including lung function impairment, respiratory symptoms, respiratory diseases, and the comparative harmful effects of combustible cigarettes and e-cigarettes.

Synthesis of Results

The results were synthesized and categorized to identify common themes, emerging patterns, and gaps in the literature. This analysis formed the foundation for understanding the health effects of cigarette smoking and e-cigarette vaping on respiratory function among adolescents and informed conclusions and recommendations regarding the comparative harmful effects of combustible cigarettes and e-cigarettes, as well as future research and public health interventions in this area.

RESULTS

The electronic cigarette is a cigarette alternative which utilizes a heater element that produces an aerosol. Even though e-cigarettes have been marketed as a healthier choice compared to smoking, there has been no scientific evidence confirming the absence of any adverse health implications caused by using these products. The research carried out indicates the presence of a total of 22 toxins apart from nicotine in the liquid contained in the cartridges and emitted by e-cigarettes. Most of these toxins have been found to be in lesser quantities as compared to those present in combustible cigarette smoke. However, there is great variability in terms of the composition of the cartridges and nicotine content in the refill solutions [6]. The prevalence of e-cigarettes is highly variable by region. The global youth prevalence of e-cigarette use is estimated to be around 9%, with country-level prevalence ranging from less than 2% to over 30%. For example, the prevalence of e-cigarette use among adolescents aged 13-15 years in Europe shows substantial variability, with some countries having prevalence less than 1%, while others have more than 20%. In addition, e-cigarette use is greater than traditional cigarette use in some cases. Moreover, data related to health show that there are certain dangers linked to the use of e-cigarettes. According to one study, in the group of never-smokers, the probability of having asthma-like symptoms was almost 39% higher for e-cigarette users than for non-users. Interestingly, a dose-response relationship was found, with daily users demonstrating the greatest risk. Another example of the adverse consequences of vaping relates to the 2019 EVALI outbreak in the United States, which led to 2,800 hospitalizations and 68 deaths, mainly in adolescents and young people. Overall, it can be said that there are numerous negative health effects caused by vaping [26-34]. Additional evidence on adolescent respiratory outcomes is provided by this study. According to this study, 12.3% of adolescents had wheezing/whistling, 17.4% had dry cough, and 1.9% had newly diagnosed asthma. Cigarette/ cigar smokers were found to be at higher risk of wheezing and respiratory disorders than those using other tobacco products. On the other hand, adolescents using alternative tobacco products were at higher risk of having new asthma diagnosis [35-37] (Table 1) 

Table 1: E-Cigarette and Cigarette Use, Exposure, and Respiratory Health Effects in Adolescents

Category

Findings

Key Statistics / Evidence

Interpretation

Device

characteristics

E-cigarettes generate aerosol via heating

component

Contains nicotine + other chemicals

Not a harmless water vapor device

Chemical exposure

Toxic substances found in ECIG fluid and emissions

22 non-nicotine toxins identified

Most levels lower than combustible cigarette smoke

Product variability

Wide variation in

ECIG fluids and nicotine strength

Different cartridge

compositions reported

Makes exposure unpredictable

Nicotine delivery

Second-generation

ECIGs mimic cigarette nicotine kinetics

Comparable nicotine delivery speed to cigarettes

High addiction potential remains

Global youth

vaping prevalence

Wide variation across countries

~9% global average (range <2% to >30%)

Strong regional

differences in vaping epidemic

Europe

adolescent vaping (13–15 yrs)

Highly variable

prevalence

<1% to >20%; some countries vaping > smoking

In some regions vaping surpasses smoking

Asia adolescent vaping

Generally lower

use rates

Japan ~3.5% ever use;

South Korea ~10%; China ~1% regular use

Lower but increasing trend

Respiratory risk (non-smokers)

E-cigarette use linked to asthma risk

~39% increased odds of asthmatic symptoms

Dose-response relationship observed

Severe outbreak (EVALI)

Acute lung injury epidemic

2,800 hospitalizations

+ 68 deaths

Mostly adolescents & young adults affected

Respiratory symptoms in adolescents

 

Follow-up study findings

12.3% wheezing,

17.4% dry cough,

1.9% new asthma

Significant respiratory burden observed

Tobacco type

comparison

Cigarette users had higher symptoms

Smoking/cigar users

more wheezing than others

Traditional smoking

still highly harmful

Alternative tobacco products

Associated with asthma development

Increased likelihood of new asthma cases

All tobacco forms increase respiratory risk

In general, the trend of increased use of tobacco and nicotine by adolescents, especially the increased prevalence of e-cigarettes and dual use with combustible tobacco, is now becoming a serious health issue. As tobacco use often starts in adolescence, prevention programs aimed at this demographic are very important for decreasing morbidity and mortality associated with tobacco use [35].

DISCUSSION

The results of the literature review suggest that there is a definite negative impact of tobacco consumption on lung functioning, with the use of combustible cigarettes showing strong association with the occurrence of symptoms such as wheezing and coughing. Population studies also show a definite linear correlation between smoking and lung functioning, including a lower FEV1 level, especially in people who suffer from wheezing and respiratory predisposition [38-40]. Adolescent tobacco exposure continues to be a serious health issue because most people become addicted to smoking during their teenage years or when they are young adults, resulting in respiratory illness [13-41] (Table 2).

Table 2: Youth Smoking Vs. Vaping: Usage Rates Across a 13-Year Period (2013–2026)

 

Year/Period

Combustible Cigarette Use (Adolescents)

E-Cigarette / Vaping Use (Adolescents)

 

Key Interpretation

 

2013–2015

~10–20% ever smoking (varies by country)

~5–10% ever vaping (early stage use)

Smoking still dominant among youth

2016–2017

~8–15% current

smoking

~7–15% ever vaping

Rapid rise in vaping begins

 

2018

~5–10% current

smoking (declining)

~10–20% vaping

(increasing)

Vaping starts surpassing smoking in some countries

 

2019

~4–8% current

smoking

~20–27% vaping (US high school peak

~27%)

Peak adolescent vaping epidemic in some regions

 

2020

 

~3–7% smoking

~14–20% vaping (decline due to COVID restrictions)

Temporary drop in vaping

 

2021–2022

 

~3–6% smoking

~14–18% vaping (steady high levels)

Vaping becomes most common nicotine product

 

2023–2024

 

~2–5% smoking

~10–15% vaping (varies by country)

Smoking continues to decline, vaping stabilizes

2025–2026

(est.)

 

~2–5% smoking

~10–16% vaping

(estimated)

Long-term health impact still under study

However, the impact of e-cigarettes on respiratory health is still ambiguous. Although some research found no relationship between e-cigarette usage and respiratory symptoms, other studies showed a positive correlation between e-cigarette use and respiratory issues like bronchitis, wheezing, and shortness of breath (Figure 2).Studies have shown that e-cigarettes can increase the risk of exacerbating asthma symptoms and being diagnosed with new-onset asthma among adolescents [35-43].

https://www.jscimedcentral.com/public/assets/images/uploads/image-1787115816-1.PNG

Figure 2: The Graphic Highlights How Smoking Traditional Cigarettes Versus Vaping Impacts The Respiratory Tract, Contrasting Their Unique Levels Of Lung Trauma, Airway Irritation, And Chronic Medical Outcomes.

Moreover, there is substantial evidence of the relationship between e-cigarette use and asthma exacerbation, as well as increased risk of smoking and substance abuse [44,45]. Nevertheless, discrepancies in various studies regarding design, definition of exposure, and outcomes measurement limit the ability for direct comparison and increase uncertainty about evidence [46]. Notably, dual usage of both combustible cigarettes and e-cigarettes has been found to present more health risks compared to using one or the other. In dual smokers, there is increased nicotine consumption along with an elevated risk of respiratory symptoms, implying that there is an element of synergy involved [35-47]. This is especially significant among adolescents since tobacco and nicotine use tend to go hand-in-hand and could result in addiction or respiratory problems. While e-cigarettes are often considered less dangerous because of their lower concentration of toxic compounds than combustible cigarettes, recent studies have shown that this may not be true. In fact, the World Health Organization has concluded that there is currently not enough evidence to claim that e-cigarettes are either safe or effective compared to approved nicotine replacement therapy [48]. Moreover, experiments have shown that even though e-cigarette vapor is much less toxic compared to cigarette smoke, it causes decreased cell viability and triggers inflammatory responses, with flavorings playing a key role in the toxicity instead of nicotine [48]. Further mechanistic and experimental data provide additional insights into possible mechanisms of harm related to e-cigarettes use. Experimental data suggests that e-cigarette aerosols include toxic chemicals such as particulates, heavy metals, carbonyls, and other compounds produced due to heating or by the device itself [49-53] (Table 3).

Table 3: How Smoking and Vaping Compare: Toxic Chemical Makeup and Respiratory Impacts

Chemical / Substance

Combustible Cigarettes

E-Cigarettes (Vapes)

Possible Respiratory Effects

Nicotine

Present

Present (usually)

Addiction, airway irritation, impaired lung development in adolescents

Tar

High amounts

Usually absent

Damages lungs, linked to chronic bronchitis and lung cancer

Carbon Monoxide

Present from tobacco burning

Usually absent or very low

Reduces oxygen delivery to tissues

Formaldehyde

Present

Can form during heating of e-liquid

Airway irritation, possible carcinogen

Acrolein

Present

Present in some aerosols

Lung inflammation, airway damage

Benzene

Present

May be present in small amounts

Cancer risk, respiratory irritation

Heavy Metals (lead, nickel, chromium)

Present

Can leach from heating coils

Toxic to lungs and other organs

Volatile Organic Compounds (VOCs)

Present

Present

Irritation of eyes, nose, throat, and lungs

Particulate Matter

High levels in smoke

Present in aerosol

Can penetrate deep into lungs

Flavoring Chemicals (e.g., diacetyl)

Rare

Common in flavored vapes

Linked to bronchiolitis (“popcorn lung”)

Propylene Glycol

Absent

Common ingredient

Throat irritation, dry cough

Vegetable Glycerin

Absent

Common ingredient

Can produce irritating byproducts when heated

Nitrosamines

High levels

Lower levels but may be present

Cancer-causing compounds

Ammonia

Present

Sometimes detected

Irritates respiratory tract

Polycyclic Aromatic Hydrocarbons (PAHs)

Present

Usually absent or very low

Lung damage and cancer risk

They can cause oxidative stress, inflammation, imbalance of redox status, and lead to lung damage. Moreover, experimental animal and cellular studies have found that long-term exposure to e-cigarette vapor affects airway epithelial barrier function, increases vulnerability to infections, and causes systemic inflammation [49 54]. Furthermore, the heating of e-liquids can result in the generation of toxic substances like formaldehyde and acrolein, which can cause injury to airway cells and endothelial cells [54]. There is also clinical evidence that demonstrates the possibility of acute as well as chronic respiratory effects. Cases of eosinophilic pneumonia, lipoid pneumonia, acute lung injury, and e-cigarette or vaping-associated lung injury (EVALI) outbreak in the US illustrate the severity of the acute effects caused by vaping [54-58]. The EVALI outbreak caused several deaths and hospitalizations and was also a major factor influencing public perception about the dangers of e-cigarettes, leading to a decline in its use and sale [59] (Table 4).

Table 4: Deaths Caused By Traditional Cigarettes vs. E-Cigarettes (2013–2026)

Year/Period

Combustible Cigarettes (Smoking)

E-Cigarettes / Vaping

Key Notes

2013–2015

~7–8 million deaths/year globally

Very few reported deaths

Smoking already a major global epidemic

2016–2018

~7–8 million deaths/year globally

Very low confirmed deaths

Vaping use increases, but mortality not established

2019

~8 million deaths globally

EVALI outbreak begins

Major lung injury outbreak linked to vaping

2020

~8 million deaths globally

~68 confirmed deaths (EVALI peak)

Mostly USA cases reported by Centers for Disease Control and Prevention

2021–2022

~8 million deaths/year globally

No large confirmed global death epidemic

EVALI cases drop sharply after regulation changes

2023–2024

~8 million deaths/year globally

Sporadic case reports only

No confirmed large-scale mortality trend

2025–2026 (est.)

~8 million deaths/year globally

No confirmed global mortality trend

Long-term effects still under research

However, there is still much uncertainty regarding the long-term respiratory effects of e-cigarette usage. Evidence from some longitudinal studies, such as those conducted using large cohorts, indicates that people who use e-cigarettes are at greater risk of developing chronic respiratory conditions, such as COPD, emphysema, chronic bronchitis, and asthma [60]. Nevertheless, early cross-sectional research was unable to prove causation, and even longitudinal studies have been restricted by factors like inadequate control for prior smoking habits as well as challenges in defining disease outcomes [60,61].Population-based trends highlight the public health impact that is increasing in significance. The use of electronic cigarettes has been on the rise, surpassing the prevalence of cigarette smoking in adolescents to maintain high levels of tobacco use among the youth [41-67]. Similar trends can be seen in adults, as reductions in cigarette smoking have come to a halt while use of e-cigarettes increases [68,69]. The issue is troubling since exposure to nicotine during the adolescent period could have negative impacts on brain development and lead to addiction problems in the future. Moreover, sociocultural and situational factors can play a role in determining the behavior of vaping. Studies show that marketing targeting certain populations, socioeconomic status, and secondhand exposure to vaping result in increased rates of vaping among at-risk populations, such as Hispanic youth, with respiratory problems as well [70-75]. Moreover, vaping has been associated with Other behavioral risks, such as consumption of alcohol and marijuana [44]. In summary, based on the current literature, it can be concluded that although combustible cigarettes continue to show consistent associations with respiratory diseases, there is no doubt that e-cigarette use poses its own set of risks, with an increasing number of associations being established between e-cigarette use and respiratory symptoms. Nevertheless, the inconsistency of study designs, as well as the lack of longitudinal research, reveals numerous gaps in the current literature that require further investigation, especially with regard to youth and other high-risk groups [76,77].

CONCLUSION

In summary, the results of the systematic literature review conducted indicate that both cigarette smoking and e-cigarette vaping have an association with harmful effects on respiratory health in adolescence. Based on the information provided by the analyzed studies, it can be concluded that cigarette smoking still has a strong association with chronic respiratory symptoms, reduced lung function, airway inflammation, asthma development, and the risk of pulmonary diseases. Despite the fact that some studies indicated that e-cigarettes might cause lower exposure to some chemicals compared with combustible cigarettes, they were still associated with adverse respiratory health outcomes such as cough, wheezing, bronchitis, pulmonary function impairment, and vulnerability to respiratory diseases. As a result, although the use of e-cigarettes might be seen as safer than smoking regular cigarettes, they are not completely harmless, especially when concerning adolescents, whose respiratory system is at the stage of active development.

REFERENCES
  1. Amos AO, Taiwo OO, Olaitan AJ, O. ES, Ayodeji AI, Ekharime EJ. Vaping Versus Smoking in Adolescents: A Mini Review of Health Risks and Behavioural Trends. SJMLS. 2026; 10.
  2. Agredo Santa P, Agredo Santa L, Martinez N, Araujo J, Cotes D, Quezada J, et al. Health Risks of Electronic Cigarettes and Vaping: A Pulmonology Perspective. Rev Científica Multidiscip SAGA. 2025; 2: 1050-1066.
  3. Judith Groner. Health effects of electronic cigarettes. Curr Probl Pediatr Adolesc Health Care. 2022; 52: 101202.
  4. Health NC for CDP and HP (US) O on S and. Health Effects of E-Cigarette Use Among U.S. Youth and Young Adults. E-Cigar Use Youth Young Adults Rep Surg Gen Internet. Centers for Disease Control and Prevention (US). 2016.
  5. Vaping versus smoking in adolescents: A mini review of health risks and behavioural trends.  ResearchGate. 2026.
  6. Harmeet Singh Rehan, Jahnavi Maini, Amrit Pal Singh Hungin. Vaping versus Smoking: A Quest for Efficacy and Safety of E-cigarette. Curr Drug Saf. 2018; 13: 92-101.
  7. Paulina Kurdy?-Bykowska , Leon Ko?mider , Dawid Konwant , Krystyna Stencel-Gabriel. Respiratory Symptoms among Adolescents in Poland: A Study on Cigarette Smokers, E-Cigarette Users, and Dual Users. 2024.
  8. Schraufnagel DE, Blasi F, Drummond MB, Lam DCL, Latif E, Rosen MJ, et al. Electronic cigarettes. A position statement of the forum of international respiratory societies. Am J Respir Crit Care Med. 2014; 190: 611-618.
  9. Meo SA, Ansary MA, Barayan FR, Almusallam AS, Almehaid AM, Alarifi NS, et al. Electronic Cigarettes: Impact on Lung Function and Fractional Exhaled Nitric Oxide Among Healthy Adults. Am J Mens Health. 2018; 13.
  10. Callahan-Lyon P. Electronic cigarettes: human health effects. Tob Control. 2014; 23: ii36-ii40.
  11. Malas M, van der Tempel J, Schwartz R, Minichiello A, Lightfoot C, Noormohamed A, et al. Electronic Cigarettes for Smoking Cessation: A Systematic Review. Nicotine Tob Res. Oxford Academic. 2016; 18: 1926-1936.
  12. Electronic Cigarette Use and Respiratory Symptoms in Adolescents. Am J Respir Crit Care Med. 2026.
  13. Effects of Cigarette Smoking on Lung Function in Adolescent Boys and Girls | NEJM. N Engl J Med. 2026.
  14. Gold DR, Wang X, Wypij D, Speizer FE, Ware JH, Dockery DW. Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med. 1996; 335: 931-937.
  15. National Academies of Sciences E, Division H and M, Practice B on PH and PH, Systems C on the R of the HE of END, Eaton DL, Kwan LY, et al. Respiratory Diseases. Public Health Consequences E-Cigar. National Academies Press (US). 2018.
  16. Rom O, Pecorelli A, Valacchi G, Reznick AZ. Are E-cigarettes a safe and good alternative to cigarette smoking? NYAS Publications. 2026.
  17. Tackett AP, Urman R, Barrington-Trimis J, Liu F, Hong H, Pentz MA, et al. Prospective study of e-cigarette use and respiratory symptoms in adolescents and young adults. Thorax. 2024; 79: 163-168.
  18. Ashraf Abdelaal Mohamed Abdelaal1. Gihan Samir Mohamed Mousa. Impact of Cigarettes Smoking on Undergraduates’ Lung Health and Functional Performance: Observational Cross-Sectional Study. Int J Prev Med. LWW. 2020; 13.
  19. Brian J. Carroll, Michael Kim, Ali Hemyari, Pooja Thakrar, Theresa E. Kump, Thomas Wade, et al. Impaired lung function following e-cigarette or vaping product use associated lung injury in the first cohort of hospitalized adolescents. Pediatric Pulmonology. 2020.
  20. Bilici M. F, Çelik M. Impact of Smoking on Respiratory Function in Young Women. Int J Sport Exercise Training Sciences – IJSETS. 2025; 11: 349-355.
  21. Tobacco Smoke Exposure, Respiratory Health, and Health-care Utilization among US Adolescents. Chest. 2020; 158: 1104–1114.
  22. Khoudigian S, Devji T, Lytvyn L, Campbell K, Hopkins R, O’Reilly D. The efficacy and short-term effects of electronic cigarettes as a method for smoking cessation: a systematic review and a meta-analysis. Int J Public Health. Springer International Publishing. 2016; 61: 257-267.
  23. Chun LF, Moazed F, Calfee CS, Matthay MA, Gotts JE. Pulmonary toxicity of e-cigarettes. Am J Physiol Lung Cell Mol Physiol. 2017; 313: 193-206.
  24. Khalid M, Amin M, Hussain SL, Ashraf R, Pasha W, Sajid MU. PULMONARY RISKS ASSOCIATED WITH E-CIGARETTE USE AMONG ADOLESCENTS: A MULTI-CENTER STUDY ON VAPING-INDUCED RESPIRATORY AILMENTS. J Popul Ther Clin Pharmacol. 2022; 29: 567-578.
  25. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Final Report-Web of Science Core Collection. 2026.
  26. Li C, Guan T. Pulmonary function and physical performance in adolescent e-cigarette users: a narrative review. Front Public Health. Frontiers. 2025; 13: 1703712.
  27. Lyzwinski LN, Naslund JA, Miller CJ, Eisenberg MJ. Global youth vaping and respiratory health: epidemiology, interventions, and policies. Npj Prim Care Respir Med. Nature Publishing Group. 2022; 32.
  28. Opoku-Mensah Y. Exploring the Long-Term Effects of Vaping on Respiratory Health among Adolescents: A Systematic Literature Review. University of Wales Trinity Saint David. 2025.
  29. Kundu A, Feore A, Abu-Zarour N, Sanchez S, Sutton M, Sachdeva K, et al. Evidence update on the respiratory health effects of vaping e-cigarettes: A systematic review and meta-analysis. Tob Induc Dis. 2025; 23.
  30. Tackett AP, Keller-Hamilton B, Smith CE, Hébert ET, Metcalf JP, Queimado L, et al. Evaluation of Respiratory Symptoms Among Youth e-Cigarette Users. JAMA Netw Open. American Medical Association. 2020; 3: e2020671–e2020671.
  31. Electronic Versus Traditional Cigarettes: Health Effects among Young Adolescents-A Scoping Review. ResearchGate. 2026.
  32. V R, Ie R, V K, A R, Bb T, Fw D, et al. The effects of electronic cigarette vapour on the lung: direct comparison to tobacco smoke. Eur Respir J. Eur Respir J. 2018; 51.
  33. Osei AD, Mirbolouk M, Orimoloye OA, Dzaye O, Uddin SMI, Dardari ZA, et al. The association between e-cigarette use and asthma among never combustible cigarette smokers: behavioral risk factor surveillance system (BRFSS) 2016 & 2017. BMC Pulm Med. 2019; 19: 180.
  34. Stevens ER, Xu S, Niaura R, Cleland CM, Sherman SE, Mai A, et al. Youth E-Cigarette Use and Functionally Important Respiratory Symptoms: The Population Assessment of Tobacco and Health (PATH) Study Waves 3 and 4. Int J Environ Res Public Health. Multidisciplinary Digital Publishing Institute. 2022; 19.
  35. Yao T, Watkins S, Sung H-Y, Wang Y, Gu D, Lyu J, et al. Association between tobacco product use and respiratory health and asthma-related interference with activities among U.S. Adolescents. Prev Med Rep. 2024; 41: 102712.
  36. Kougias M, Vardavas CI, Anagnostopoulos N, Matsunaga Y, Tzwrtzi A, Lymberi M, et al. The acute effect of cigarette smoking on the respiratory function and FENO production among young smokers. Exp Lung Res. 2013; 39: 359-364.
  37. The acute effect of cigarette smoking on the respiratory function and FENO production among young smokers. Exp Lung Res. 2026.
  38. Jaakkola MS, Jaakkola JJ, Ernst P, Becklake MR. Ventilatory lung function in young cigarette smokers: a study of susceptibility. Eur Respir J. 1991; 4: 643-650.
  39. Chaiton M, Pienkowski M, Musani I, Bondy SJ, Cohen JE, Dubray J, et al. Smoking, e-cigarettes and the effect on respiratory symptoms among a population sample of youth: Retrospective cohort study. Tob Induc Dis. 2023; 21: 08.
  40. Cao DJ, Aldy K, Hsu S, McGetrick M, Verbeck G, De Silva I, et al. Review of Health Consequences of Electronic Cigarettes and the Outbreak of Electronic Cigarette, or Vaping, Product Use-Associated Lung Injury. J Med Toxicol Off J Am Coll Med Toxicol. 2020; 16: 295-310.
  41. Singh T, Arrazola RA, Corey CG, Husten CG, Neff LJ, Homa DM, et al. Tobacco Use Among Middle and High School Students--United States, 2011-2015. MMWR Morb Mortal Wkly Rep. 2016; 65: 361-367.
  42. Nasir NI, Ja’afar MH, Ahmad N. Systematic review of lung function assessment among youth and young adults e-cigarette users: Current tools and emerging methods. PloS One. 2026; 21: e0342500.
  43. Systematic review of lung function assessment among youth and young adults e-cigarette users: Current tools and emerging methods | PLOS One. 2026.
  44. Golder S, Hartwell G, Barnett LM, Nash SG, Petticrew M, Glover RE. Vaping and harm in young people: umbrella review. Tob Control. BMJ Publishing Group Ltd. 2025.
  45. Adolescent e-cigarette or vaping product use-associated lung injury: A case series and review of the literature - Singh - 2022 - Pediatric Pulmonology - Wiley Online Library. 2026.
  46. Sargent JD, Halenar MJ, Edwards KC, Woloshin S, Schwartz L, Emond J, et al. Tobacco Use and Respiratory Symptoms Among Adults: Findings From the Longitudinal Population Assessment of Tobacco and Health (PATH) Study 2014-2016. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2022; 24: 1607-1618.
  47. Honeycutt L, Huerne K, Miller A, Wennberg E, Filion KB, Grad R, et al. A systematic review of the effects of e-cigarette use on lung function. Npj Prim Care Respir Med. Nature Publishing Group. 2022; 32: 45.
  48. Cervellati F, Muresan XM, Sticozzi C, Gambari R, Montagner G, Forman HJ, et al. Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. Toxicol Vitro Int J Publ Assoc BIBRA. 2014; 28: 999-1005.
  49. Lerner CA, Sundar IK, Yao H, Gerloff J, Ossip DJ, McIntosh S, et al. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PloS One. 2015; 10: e0116732.
  50. Association of E-Cigarette Use With Respiratory Disease Among Adults: A Longitudinal Analysis. Am J Prev Med. Elsevier. 2020; 58: 182-190.
  51. Arshad SH, Hodgekiss C, Holloway JW, Kurukulaaratchy R, Karmaus W, Zhang H, et al. Association of asthma and smoking with lung function impairment in adolescence and early adulthood: the Isle of Wight Birth Cohort Study. Eur Respir J. 2020; 55: 1900477.
  52. Soneji S, Barrington-Trimis JL, Wills TA, Leventhal AM, Unger JB, Gibson LA, et al. Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults: A Systematic Review and Meta-analysis. JAMA Pediatr. American Medical Association. 2017; 171: 788-797.

  53. Antwi GO, Rhodes DL. Association between E-cigarette use and chronic obstructive pulmonary disease in non-asthmatic adults in the USA. J Public Health. Oxford Academic. 2022; 44: 158-164.
  54. Crotty Alexander LE, Drummond CA, Hepokoski M, Mathew D, Moshensky A, Willeford A, et al. Chronic inhalation of e-cigarette vapor containing nicotine disrupts airway barrier function and induces systemic inflammation and multiorgan fibrosis in mice. Am J Physiol Regul Integr Comp Physiol. 2018; 314: R834-847.
  55. Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study-Web of Science Core Collection. 2026.
  56. Association of vaping with respiratory symptoms in U.S. young adults: Nicotine, cannabis, and dual vaping. Prev Med. Academic Press. 2024; 189: 108175.
  57. Li D, Sundar IK, McIntosh S, Ossip DJ, Goniewicz ML, O’Connor RJ, et al. Association of smoking and electronic cigarette use with wheezing and related respiratory symptoms in adults: cross-sectional results from the Population Assessment of Tobacco and Health (PATH) study, wave 2. Tob Control. BMJ Publishing Group Ltd. 2020; 29: 140-147.
  58. Am L, Dr S, Mg K, Jb U, S S, Nr R, et al. Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence. JAMA. JAMA. 2015; 314.
  59. Kreslake JM, Diaz MC, Shinaba M, Vallone DM, Hair EC. Youth and young adult risk perceptions and behaviours in response to an outbreak of e-cigarette/vaping-associated lung injury (EVALI) in the USA. Tob Control. 2022; 31: 88-97.
  60. Xie W, Kathuria H, Galiatsatos P, Blaha MJ, Hamburg NM, Robertson RM, et al. Association of Electronic Cigarette Use With Incident Respiratory Conditions Among US Adults From 2013 to 2018. JAMA Netw Open. American Medical Association. 2020; 3: e2020816-e2020816.
  61. A review of toxic effects of electronic cigarettes/vaping in adolescents and young adults. Crit Rev Toxicol. 2026.
  62. E-cigarette use and subsequent smoking in adolescents and young adults: a perspective. Expert Rev Respir      Med. 2026.
  63. Alqahtani MM, Alenezi FK, Almeshari MA, Alanazi AM, Taleb ZB, Kalan MEE, et al. E-cigarette use and respiratory symptoms in adults: A systematic review and meta-analysis. Tob Induc Dis. 2023; 21: 168.
  64. E-cigarette use and respiratory disorder in an adult sample. Drug Alcohol Depend. Elsevier. 2019; 194: 363-370.
  65. Schweitzer RJ, Wills TA, Tam E, Pagano I, Choi K. E-cigarette use and asthma in a multiethnic sample of adolescents. Prev Med. 2017; 105: 226-231.
  66. E-cigarette use and adverse respiratory symptoms among adolescents and Young adults in the United States. Prev Med. Academic Press. 2021; 153: 106766.
  67. Sd K, A O, Lm R, C H, Ao G. E-Cigarette Use Among Adolescents Not Susceptible to Using Cigarettes. Prev Chronic Dis. Prev Chronic Dis. 2018; 15.
  68. Agaku IT, King BA, Husten CG, Bunnell R, Ambrose BK, Hu SS, et al. Tobacco product use among adults--United States, 2012-2013. MMWR Morb Mortal Wkly Rep. 2014; 63: 542-547.
  69. Hamberger ES, Halpern-Felsher B. Vaping in adolescents: epidemiology and respiratory harm. Curr Opin Pediatr. 2020; 32: 378-383.
  70. Effect of active smoking on asthma symptoms, pulmonary function, and BHR in adolescents -Yoo-2009-Pediatric Pulmonolog -Wiley Online Library. 2026
  71. Acosta M. Vaping and Respiratory Health: A Literature Review Focused on Hispanic Adolescents in the Rio Grande Valley. DHR Proc. 2025; 4: 42-54.
  72. Tager IB, Muñoz A, Rosner B, Weiss ST, Carey V, Speizer FE. Effect of cigarette smoking on the pulmonary function of children and adolescents. Am Rev Respir Dis. 1985; 131: 752-759.
  73. E-cigarettes use and respiratory symptoms in asthmatic and non-asthmatic adolescents – a systematic review. ResearchGate. 2026.
  74. Rahman MA, Hann N, Wilson A, Mnatzaganian G, Worrall-Carter L. E-Cigarettes and Smoking Cessation: Evidence from a Systematic Review and Meta-Analysis. PLOS ONE. Public Library of Science. 2015; 10: e0122544.
  75. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med. Elsevier. 2016; 4: 116-128.
  76. Helbig O, Ciszek G, Bobrowski B, Derlatka H, Drugacz J, Kontek K, et al. The impact of electronic cigarettes on the respiratory system: a narrative review. Arch Euromedica. 2025; 15.
  77. Thakrar PD, Boyd KP, Swanson CP, Wideburg E, Kumbhar SS. E-cigarette, or vaping, product use-associated lung injury in adolescents: a review of imaging features. Pediatr Radiol. Springer Berlin Heidelberg. 2020; 50: 338-444.

Christina R, Silva D, Ekanayake A, Madurapperuma W (2026) Health Effects of Cigarette Smoking and E-Cigarette Vaping on Respiratory Function among Adolescents: Systematic Literature Review. J Addict Med Ther 13(1): 1054.

Received : 24 Jun 2026
Accepted : 30 Jul 2026
Published : 31 Jul 2026
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X